Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant S1 Antigen COVID-19 Vaccine Booster Trial
NCT05016934Phase 2Withdrawn
- Sponsor
- HCor
- Start
- Nov 2021
- Primary completion
- Mar 2022
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19), sponsored by HCor. Planned start Nov 2021; status: withdrawn.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05016934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05016934.